在COSMOS研究中,古塞尔库马布改善了患有牛皮关节炎和对瘤坏死因子抑制剂反应不足的参与者患者报告的结果
Laure Gossec1,2, Xenofon Baraliakos3, James Galloway4
1Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France. laure.gossec@aphp.fr.
Rheumatology and therapy
|January 23, 2026
概括
古塞尔库马布迅速改善了牛皮关节炎 (PsA) 患者的患者报告结果,这些患者对TNFi治疗反应不足. 早在第8周就观察到显著的改善,持续的好处持续到第48周.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 牛皮关节炎 (PsA) 是一种慢性炎症性疾病.
- 瘤坏死因子抑制剂 (TNFi) 是一种常见的治疗方法.
- 一些患有PsA的患者对TNFi治疗有不充分的反应.
研究的目的:
- 评估使用guselkumab的患者报告结果 (PROs) 中获得的临床重要改善 (MCII) 的程度.
- 评估活跃的PsA和TNFi-不充分反应 (TNFi-IR) 的患者的MCII实现的速度和程度.
主要方法:
- 后期分析COSMOS研究的第3b阶段.
- 患有PsA和TNFi-IR的参与者被随机分配给guselkumab或安慰剂.
- 使用Cox和后勤回归分别确定了MCII实现的时间和MCII率.
主要成果:
- 与安慰剂相比,Guselkumab治疗在24周内在大多数PRO中实现了显著更快的MCII,与安慰剂相比.
- 随着古塞尔库马布的使用,早在第8周就观察到PRO的显著改善.
- 所有PRO的MCII成绩率在第48周增加.
结论:
- 古塞尔库马布在患者报告的皮肤和关节干扰和疼痛症状方面表现出快速的MCII成就.
- 还注意到疲劳,功能状态和生活质量的改善.
- 响应率在古塞尔库马布治疗的第48周继续增加.
相关概念视频
Necrosis
6.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.4K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
312
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
312
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Eukaryotic Transcription Inhibitors
10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Data Reporting and Recording
5.4K
Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.4K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K


